<DOC>
	<DOCNO>NCT02941731</DOCNO>
	<brief_summary>The purpose study investigate bioequivalence administration HIP1403 HGP0919 suspension healthy male volunteer .</brief_summary>
	<brief_title>Evaluating Bioequivalence HIP1403 HGP0919 Suspensions</brief_title>
	<detailed_description>A randomized , open-label , single dose , crossover clinical trial investigate compare pharmacokinetics HIP1403 HGP0919 suspension healthy male volunteer .</detailed_description>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>1 . Healthy male volunteer , age 19 45 year . 2 . The result Body Mass Index ( BMI ) less 18 kg/m2 , 29 kg/m2 . 3 . Subjects ability comprehend objective , content study property study drug participate trial willingness sign inform consent writing . 1 . Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study , include clinically significant disorder kidney , liver , cardiovascular system , respiratory system , endocrine system , neuropsychiatric system . 2 . Positive serology HBs antigen , HCV antibody , HIV antigen</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>